APO-REPAGLINIDE
APOTEX INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is APO-REPAGLINIDE discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that APO-REPAGLINIDE has been permanently discontinued (last updated September 15, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is APO-REPAGLINIDE not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
TEVA-REPAGLINIDE
TEVA CANADA LIMITED
MYLAN-REPAGLINIDE
MYLAN PHARMACEUTICALS ULC
AURO-REPAGLINIDE
AURO PHARMA INC
REPAGLINIDE
PRO DOC LIMITEE
JAMP REPAGLINIDE
JAMP PHARMA CORPORATION
SANDOZ REPAGLINIDE
SANDOZ CANADA INCORPORATED
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02355671
Tier
Unrated
Last Updated
2018-09-15
Reason for Shortage
Business reasons
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178